Z L Yang

The paper shows that restoring Klf9 expression during cardiac hypertrophy initially inhibits hypertrophy but leads to early-onset heart failure.

This paper introduces GZL626, a novel AR degrader that targets the N-terminal domain and RNF213-UBE2J2 complex, effectively degrading AR and AR-V7 and showing antitumor and antiviral activity.